Northeast Investment Management Has $2.61 Million Stake in The Clorox Company $CLX

Northeast Investment Management lowered its stake in shares of The Clorox Company (NYSE:CLX) by 24.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 25,924 shares of the company’s stock after selling 8,565 shares during the quarter. Northeast Investment Management’s holdings in Clorox were worth $2,614,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the stock. Meridian Wealth Management LLC grew its holdings in Clorox by 8.9% during the fourth quarter. Meridian Wealth Management LLC now owns 2,705 shares of the company’s stock worth $273,000 after buying an additional 220 shares in the last quarter. Blackhawk Capital Partners LLC grew its holdings in Clorox by 8.9% during the fourth quarter. Blackhawk Capital Partners LLC now owns 11,924 shares of the company’s stock worth $1,202,000 after buying an additional 975 shares in the last quarter. Mirabaud Asset Management Ltd grew its holdings in Clorox by 158.6% during the fourth quarter. Mirabaud Asset Management Ltd now owns 14,253 shares of the company’s stock worth $1,437,000 after buying an additional 8,742 shares in the last quarter. Swiss Life Asset Management Ltd grew its holdings in Clorox by 12.8% during the fourth quarter. Swiss Life Asset Management Ltd now owns 97,470 shares of the company’s stock worth $9,828,000 after buying an additional 11,044 shares in the last quarter. Finally, Farmers & Merchants Investments Inc. grew its holdings in Clorox by 14.2% during the fourth quarter. Farmers & Merchants Investments Inc. now owns 25,293 shares of the company’s stock worth $2,550,000 after buying an additional 3,136 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.2%

CLX stock opened at $89.08 on Wednesday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a market capitalization of $10.77 billion, a price-to-earnings ratio of 14.46, a PEG ratio of 0.46 and a beta of 0.59. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $138.03. The stock has a fifty day moving average of $103.83 and a 200-day moving average of $107.43.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts predict that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd were issued a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, April 22nd. This represents a $4.96 annualized dividend and a dividend yield of 5.6%. Clorox’s dividend payout ratio (DPR) is presently 80.52%.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. TD Cowen upped their price target on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a report on Tuesday, March 31st. JPMorgan Chase & Co. decreased their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Finally, Citigroup decreased their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $103.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.